(2012) derived a PRS from five highly significant SNPs to improve predictions when used in combination with clinical risk factors, compared to clinical risk factors alone.
← all excerpts
Polygenic risk scores: An overview from bench to bedside for personalised medicine.
2
—
—
The sentences
Lastly, the GIFT trial, which is the largest and most recent warfarin pharmacogenomics trial, assessed perioperative warfarin dosing and reported a decrease in a composite clinical outcome using the pharmacogenomic dosing algorithm, driven mostly by a reduction in episodes of INR >4 and a borderline significant reduction in major bleeding ( Gage et al., 2017 ).